nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Toremifene—ESR1—ovarian cancer	0.00361	0.314	CrCbGaD
Doxylamine—Urticaria—Topotecan—ovarian cancer	0.00249	0.00252	CcSEcCtD
Doxylamine—Urethral disorder—Paclitaxel—ovarian cancer	0.00249	0.00252	CcSEcCtD
Doxylamine—Urticaria—Melphalan—ovarian cancer	0.00244	0.00247	CcSEcCtD
Doxylamine—Diarrhoea—Chlorambucil—ovarian cancer	0.00241	0.00244	CcSEcCtD
Doxylamine—Erythema multiforme—Paclitaxel—ovarian cancer	0.0024	0.00243	CcSEcCtD
Doxylamine—Dyspnoea—Vinorelbine—ovarian cancer	0.00239	0.00242	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00238	0.0024	CcSEcCtD
Doxylamine—Eye disorder—Paclitaxel—ovarian cancer	0.00237	0.0024	CcSEcCtD
Doxylamine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00236	0.00238	CcSEcCtD
Doxylamine—Flushing—Paclitaxel—ovarian cancer	0.00236	0.00238	CcSEcCtD
Doxylamine—Decreased appetite—Vinorelbine—ovarian cancer	0.00233	0.00236	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00232	0.00234	CcSEcCtD
Doxylamine—Fatigue—Vinorelbine—ovarian cancer	0.00231	0.00234	CcSEcCtD
Doxylamine—Hypersensitivity—Topotecan—ovarian cancer	0.00231	0.00234	CcSEcCtD
Doxylamine—Constipation—Vinorelbine—ovarian cancer	0.00229	0.00232	CcSEcCtD
Doxylamine—Immune system disorder—Paclitaxel—ovarian cancer	0.00229	0.00232	CcSEcCtD
Doxylamine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00229	0.00232	CcSEcCtD
Doxylamine—Hypersensitivity—Melphalan—ovarian cancer	0.00226	0.00229	CcSEcCtD
Doxylamine—Asthenia—Topotecan—ovarian cancer	0.00225	0.00228	CcSEcCtD
Doxylamine—Vomiting—Chlorambucil—ovarian cancer	0.00224	0.00227	CcSEcCtD
Doxylamine—Agranulocytosis—Docetaxel—ovarian cancer	0.00224	0.00226	CcSEcCtD
Doxylamine—Pruritus—Topotecan—ovarian cancer	0.00222	0.00224	CcSEcCtD
Doxylamine—Erythema—Paclitaxel—ovarian cancer	0.00221	0.00224	CcSEcCtD
Doxylamine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00221	0.00224	CcSEcCtD
Doxylamine—Asthenia—Melphalan—ovarian cancer	0.0022	0.00223	CcSEcCtD
Doxylamine—Pruritus—Melphalan—ovarian cancer	0.00217	0.0022	CcSEcCtD
Doxylamine—Hepatitis—Docetaxel—ovarian cancer	0.00215	0.00218	CcSEcCtD
Doxylamine—Diarrhoea—Topotecan—ovarian cancer	0.00215	0.00217	CcSEcCtD
Doxylamine—Tamoxifen—CYP1B1—ovarian cancer	0.00214	0.186	CrCbGaD
Doxylamine—Urticaria—Vinorelbine—ovarian cancer	0.00213	0.00216	CcSEcCtD
Doxylamine—Urinary tract disorder—Docetaxel—ovarian cancer	0.00213	0.00215	CcSEcCtD
Doxylamine—Muscle spasms—Paclitaxel—ovarian cancer	0.00213	0.00215	CcSEcCtD
Doxylamine—Urethral disorder—Docetaxel—ovarian cancer	0.00211	0.00213	CcSEcCtD
Doxylamine—Diarrhoea—Melphalan—ovarian cancer	0.0021	0.00213	CcSEcCtD
Doxylamine—Diplopia—Epirubicin—ovarian cancer	0.0021	0.00212	CcSEcCtD
Doxylamine—Nausea—Chlorambucil—ovarian cancer	0.00209	0.00212	CcSEcCtD
Doxylamine—Dizziness—Topotecan—ovarian cancer	0.00207	0.0021	CcSEcCtD
Doxylamine—Tremor—Paclitaxel—ovarian cancer	0.00207	0.0021	CcSEcCtD
Doxylamine—Affect lability—Epirubicin—ovarian cancer	0.00207	0.00209	CcSEcCtD
Doxylamine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00205	0.00208	CcSEcCtD
Doxylamine—Erythema multiforme—Docetaxel—ovarian cancer	0.00204	0.00206	CcSEcCtD
Doxylamine—Agitation—Paclitaxel—ovarian cancer	0.00203	0.00206	CcSEcCtD
Doxylamine—Angioedema—Paclitaxel—ovarian cancer	0.00202	0.00204	CcSEcCtD
Doxylamine—Eye disorder—Docetaxel—ovarian cancer	0.00201	0.00204	CcSEcCtD
Doxylamine—Cardiac disorder—Docetaxel—ovarian cancer	0.002	0.00202	CcSEcCtD
Doxylamine—Flushing—Docetaxel—ovarian cancer	0.002	0.00202	CcSEcCtD
Doxylamine—Vomiting—Topotecan—ovarian cancer	0.00199	0.00202	CcSEcCtD
Doxylamine—Malaise—Paclitaxel—ovarian cancer	0.00199	0.00202	CcSEcCtD
Doxylamine—Mood swings—Epirubicin—ovarian cancer	0.00199	0.00201	CcSEcCtD
Doxylamine—Vertigo—Paclitaxel—ovarian cancer	0.00199	0.00201	CcSEcCtD
Doxylamine—Leukopenia—Paclitaxel—ovarian cancer	0.00198	0.002	CcSEcCtD
Doxylamine—Rash—Topotecan—ovarian cancer	0.00198	0.002	CcSEcCtD
Doxylamine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00198	0.002	CcSEcCtD
Doxylamine—Dermatitis—Topotecan—ovarian cancer	0.00198	0.002	CcSEcCtD
Doxylamine—Palpitations—Paclitaxel—ovarian cancer	0.00195	0.00198	CcSEcCtD
Doxylamine—Vomiting—Melphalan—ovarian cancer	0.00195	0.00197	CcSEcCtD
Doxylamine—Dehydration—Epirubicin—ovarian cancer	0.00195	0.00197	CcSEcCtD
Doxylamine—Immune system disorder—Docetaxel—ovarian cancer	0.00194	0.00197	CcSEcCtD
Doxylamine—Diplopia—Doxorubicin—ovarian cancer	0.00194	0.00196	CcSEcCtD
Doxylamine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00194	0.00196	CcSEcCtD
Doxylamine—Rash—Melphalan—ovarian cancer	0.00194	0.00196	CcSEcCtD
Doxylamine—Dermatitis—Melphalan—ovarian cancer	0.00193	0.00196	CcSEcCtD
Doxylamine—Asthenia—Vinorelbine—ovarian cancer	0.00192	0.00195	CcSEcCtD
Doxylamine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00192	0.00194	CcSEcCtD
Doxylamine—Convulsion—Paclitaxel—ovarian cancer	0.00192	0.00194	CcSEcCtD
Doxylamine—Affect lability—Doxorubicin—ovarian cancer	0.00191	0.00193	CcSEcCtD
Doxylamine—Pruritus—Vinorelbine—ovarian cancer	0.0019	0.00192	CcSEcCtD
Doxylamine—Breast disorder—Epirubicin—ovarian cancer	0.0019	0.00192	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00189	0.00191	CcSEcCtD
Doxylamine—Nasopharyngitis—Epirubicin—ovarian cancer	0.00188	0.0019	CcSEcCtD
Doxylamine—Anxiety—Paclitaxel—ovarian cancer	0.00188	0.0019	CcSEcCtD
Doxylamine—Erythema—Docetaxel—ovarian cancer	0.00187	0.0019	CcSEcCtD
Doxylamine—Nausea—Topotecan—ovarian cancer	0.00186	0.00188	CcSEcCtD
Doxylamine—Discomfort—Paclitaxel—ovarian cancer	0.00186	0.00188	CcSEcCtD
Doxylamine—Dry mouth—Paclitaxel—ovarian cancer	0.00184	0.00186	CcSEcCtD
Doxylamine—Mood swings—Doxorubicin—ovarian cancer	0.00184	0.00186	CcSEcCtD
Doxylamine—Diarrhoea—Vinorelbine—ovarian cancer	0.00184	0.00186	CcSEcCtD
Doxylamine—Nausea—Melphalan—ovarian cancer	0.00182	0.00184	CcSEcCtD
Doxylamine—Confusional state—Paclitaxel—ovarian cancer	0.00182	0.00184	CcSEcCtD
Doxylamine—Dehydration—Doxorubicin—ovarian cancer	0.00181	0.00183	CcSEcCtD
Doxylamine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.0018	0.00183	CcSEcCtD
Doxylamine—Muscle spasms—Docetaxel—ovarian cancer	0.0018	0.00182	CcSEcCtD
Doxylamine—Pancreatitis—Epirubicin—ovarian cancer	0.00178	0.0018	CcSEcCtD
Doxylamine—Dizziness—Vinorelbine—ovarian cancer	0.00177	0.00179	CcSEcCtD
Doxylamine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00177	0.00179	CcSEcCtD
Doxylamine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00177	0.00179	CcSEcCtD
Doxylamine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00177	0.00179	CcSEcCtD
Doxylamine—Tachycardia—Paclitaxel—ovarian cancer	0.00176	0.00178	CcSEcCtD
Doxylamine—Breast disorder—Doxorubicin—ovarian cancer	0.00175	0.00178	CcSEcCtD
Doxylamine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00175	0.00177	CcSEcCtD
Doxylamine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00174	0.00176	CcSEcCtD
Doxylamine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00174	0.00176	CcSEcCtD
Doxylamine—Pancytopenia—Epirubicin—ovarian cancer	0.00172	0.00174	CcSEcCtD
Doxylamine—Anorexia—Paclitaxel—ovarian cancer	0.00172	0.00174	CcSEcCtD
Doxylamine—Vomiting—Vinorelbine—ovarian cancer	0.00171	0.00173	CcSEcCtD
Doxylamine—Rash—Vinorelbine—ovarian cancer	0.00169	0.00171	CcSEcCtD
Doxylamine—Dermatitis—Vinorelbine—ovarian cancer	0.00169	0.00171	CcSEcCtD
Doxylamine—Hypotension—Paclitaxel—ovarian cancer	0.00169	0.00171	CcSEcCtD
Doxylamine—Leukopenia—Docetaxel—ovarian cancer	0.00168	0.0017	CcSEcCtD
Doxylamine—Palpitations—Docetaxel—ovarian cancer	0.00166	0.00168	CcSEcCtD
Doxylamine—Pancreatitis—Doxorubicin—ovarian cancer	0.00165	0.00166	CcSEcCtD
Doxylamine—Insomnia—Paclitaxel—ovarian cancer	0.00163	0.00165	CcSEcCtD
Doxylamine—Convulsion—Docetaxel—ovarian cancer	0.00162	0.00164	CcSEcCtD
Doxylamine—Drowsiness—Epirubicin—ovarian cancer	0.00162	0.00164	CcSEcCtD
Doxylamine—Dyspnoea—Paclitaxel—ovarian cancer	0.00161	0.00163	CcSEcCtD
Doxylamine—Somnolence—Paclitaxel—ovarian cancer	0.0016	0.00162	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.0016	0.00162	CcSEcCtD
Doxylamine—Pancytopenia—Doxorubicin—ovarian cancer	0.00159	0.00161	CcSEcCtD
Doxylamine—Nausea—Vinorelbine—ovarian cancer	0.00159	0.00161	CcSEcCtD
Doxylamine—Decreased appetite—Paclitaxel—ovarian cancer	0.00157	0.00159	CcSEcCtD
Doxylamine—Dry mouth—Docetaxel—ovarian cancer	0.00156	0.00158	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00156	0.00158	CcSEcCtD
Doxylamine—Fatigue—Paclitaxel—ovarian cancer	0.00156	0.00157	CcSEcCtD
Doxylamine—Sweating—Epirubicin—ovarian cancer	0.00155	0.00157	CcSEcCtD
Doxylamine—Constipation—Paclitaxel—ovarian cancer	0.00154	0.00156	CcSEcCtD
Doxylamine—Confusional state—Docetaxel—ovarian cancer	0.00154	0.00156	CcSEcCtD
Doxylamine—Toremifene—ABCB1—ovarian cancer	0.00154	0.133	CrCbGaD
Doxylamine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00153	0.00155	CcSEcCtD
Doxylamine—Agranulocytosis—Epirubicin—ovarian cancer	0.00151	0.00153	CcSEcCtD
Doxylamine—Nervous system disorder—Docetaxel—ovarian cancer	0.0015	0.00152	CcSEcCtD
Doxylamine—Thrombocytopenia—Docetaxel—ovarian cancer	0.0015	0.00151	CcSEcCtD
Doxylamine—Drowsiness—Doxorubicin—ovarian cancer	0.0015	0.00151	CcSEcCtD
Doxylamine—Tachycardia—Docetaxel—ovarian cancer	0.00149	0.00151	CcSEcCtD
Doxylamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00149	0.0015	CcSEcCtD
Doxylamine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00148	0.0015	CcSEcCtD
Doxylamine—Bradycardia—Epirubicin—ovarian cancer	0.00148	0.0015	CcSEcCtD
Doxylamine—Anorexia—Docetaxel—ovarian cancer	0.00146	0.00147	CcSEcCtD
Doxylamine—Hepatitis—Epirubicin—ovarian cancer	0.00145	0.00147	CcSEcCtD
Doxylamine—Tamoxifen—ESR1—ovarian cancer	0.00144	0.125	CrCbGaD
Doxylamine—Sweating—Doxorubicin—ovarian cancer	0.00143	0.00145	CcSEcCtD
Doxylamine—Urinary tract disorder—Epirubicin—ovarian cancer	0.00143	0.00145	CcSEcCtD
Doxylamine—Urticaria—Paclitaxel—ovarian cancer	0.00143	0.00145	CcSEcCtD
Doxylamine—Hypotension—Docetaxel—ovarian cancer	0.00143	0.00145	CcSEcCtD
Doxylamine—Urethral disorder—Epirubicin—ovarian cancer	0.00142	0.00144	CcSEcCtD
Doxylamine—Agranulocytosis—Doxorubicin—ovarian cancer	0.0014	0.00141	CcSEcCtD
Doxylamine—Insomnia—Docetaxel—ovarian cancer	0.00138	0.0014	CcSEcCtD
Doxylamine—Erythema multiforme—Epirubicin—ovarian cancer	0.00137	0.00139	CcSEcCtD
Doxylamine—Bradycardia—Doxorubicin—ovarian cancer	0.00137	0.00138	CcSEcCtD
Doxylamine—Dyspnoea—Docetaxel—ovarian cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Somnolence—Docetaxel—ovarian cancer	0.00136	0.00138	CcSEcCtD
Doxylamine—Eye disorder—Epirubicin—ovarian cancer	0.00136	0.00137	CcSEcCtD
Doxylamine—Cardiac disorder—Epirubicin—ovarian cancer	0.00135	0.00136	CcSEcCtD
Doxylamine—Flushing—Epirubicin—ovarian cancer	0.00135	0.00136	CcSEcCtD
Doxylamine—Hepatitis—Doxorubicin—ovarian cancer	0.00134	0.00136	CcSEcCtD
Doxylamine—Decreased appetite—Docetaxel—ovarian cancer	0.00133	0.00134	CcSEcCtD
Doxylamine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00133	0.00134	CcSEcCtD
Doxylamine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00133	0.00134	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00132	0.00134	CcSEcCtD
Doxylamine—Fatigue—Docetaxel—ovarian cancer	0.00132	0.00133	CcSEcCtD
Doxylamine—Urethral disorder—Doxorubicin—ovarian cancer	0.00132	0.00133	CcSEcCtD
Doxylamine—Immune system disorder—Epirubicin—ovarian cancer	0.00131	0.00133	CcSEcCtD
Doxylamine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00131	0.00132	CcSEcCtD
Doxylamine—Constipation—Docetaxel—ovarian cancer	0.00131	0.00132	CcSEcCtD
Doxylamine—Asthenia—Paclitaxel—ovarian cancer	0.00129	0.00131	CcSEcCtD
Doxylamine—Pruritus—Paclitaxel—ovarian cancer	0.00128	0.00129	CcSEcCtD
Doxylamine—Erythema multiforme—Doxorubicin—ovarian cancer	0.00127	0.00128	CcSEcCtD
Doxylamine—Erythema—Epirubicin—ovarian cancer	0.00126	0.00128	CcSEcCtD
Doxylamine—Feeling abnormal—Docetaxel—ovarian cancer	0.00126	0.00127	CcSEcCtD
Doxylamine—Eye disorder—Doxorubicin—ovarian cancer	0.00126	0.00127	CcSEcCtD
Doxylamine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00125	0.00126	CcSEcCtD
Doxylamine—Flushing—Doxorubicin—ovarian cancer	0.00125	0.00126	CcSEcCtD
Doxylamine—Diarrhoea—Paclitaxel—ovarian cancer	0.00123	0.00125	CcSEcCtD
Doxylamine—Muscle spasms—Epirubicin—ovarian cancer	0.00122	0.00123	CcSEcCtD
Doxylamine—Immune system disorder—Doxorubicin—ovarian cancer	0.00121	0.00123	CcSEcCtD
Doxylamine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00121	0.00122	CcSEcCtD
Doxylamine—Dizziness—Paclitaxel—ovarian cancer	0.00119	0.00121	CcSEcCtD
Doxylamine—Ill-defined disorder—Epirubicin—ovarian cancer	0.00117	0.00119	CcSEcCtD
Doxylamine—Erythema—Doxorubicin—ovarian cancer	0.00117	0.00118	CcSEcCtD
Doxylamine—Agitation—Epirubicin—ovarian cancer	0.00116	0.00117	CcSEcCtD
Doxylamine—Vomiting—Paclitaxel—ovarian cancer	0.00115	0.00116	CcSEcCtD
Doxylamine—Malaise—Epirubicin—ovarian cancer	0.00114	0.00115	CcSEcCtD
Doxylamine—Rash—Paclitaxel—ovarian cancer	0.00114	0.00115	CcSEcCtD
Doxylamine—Dermatitis—Paclitaxel—ovarian cancer	0.00114	0.00115	CcSEcCtD
Doxylamine—Vertigo—Epirubicin—ovarian cancer	0.00114	0.00115	CcSEcCtD
Doxylamine—Leukopenia—Epirubicin—ovarian cancer	0.00113	0.00114	CcSEcCtD
Doxylamine—Hypersensitivity—Docetaxel—ovarian cancer	0.00113	0.00114	CcSEcCtD
Doxylamine—Muscle spasms—Doxorubicin—ovarian cancer	0.00112	0.00114	CcSEcCtD
Doxylamine—Palpitations—Epirubicin—ovarian cancer	0.00112	0.00113	CcSEcCtD
Doxylamine—Asthenia—Docetaxel—ovarian cancer	0.0011	0.00111	CcSEcCtD
Doxylamine—Convulsion—Epirubicin—ovarian cancer	0.0011	0.00111	CcSEcCtD
Doxylamine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00109	0.0011	CcSEcCtD
Doxylamine—Pruritus—Docetaxel—ovarian cancer	0.00108	0.00109	CcSEcCtD
Doxylamine—Agitation—Doxorubicin—ovarian cancer	0.00107	0.00109	CcSEcCtD
Doxylamine—Anxiety—Epirubicin—ovarian cancer	0.00107	0.00108	CcSEcCtD
Doxylamine—Nausea—Paclitaxel—ovarian cancer	0.00107	0.00108	CcSEcCtD
Doxylamine—Discomfort—Epirubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Doxylamine—Malaise—Doxorubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Doxylamine—Dry mouth—Epirubicin—ovarian cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Vertigo—Doxorubicin—ovarian cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Leukopenia—Doxorubicin—ovarian cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Diarrhoea—Docetaxel—ovarian cancer	0.00105	0.00106	CcSEcCtD
Doxylamine—Confusional state—Epirubicin—ovarian cancer	0.00104	0.00105	CcSEcCtD
Doxylamine—Palpitations—Doxorubicin—ovarian cancer	0.00103	0.00105	CcSEcCtD
Doxylamine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00103	0.00104	CcSEcCtD
Doxylamine—Convulsion—Doxorubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Doxylamine—Nervous system disorder—Epirubicin—ovarian cancer	0.00101	0.00102	CcSEcCtD
Doxylamine—Dizziness—Docetaxel—ovarian cancer	0.00101	0.00102	CcSEcCtD
Doxylamine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00101	0.00102	CcSEcCtD
Doxylamine—Tachycardia—Epirubicin—ovarian cancer	0.00101	0.00102	CcSEcCtD
Doxylamine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000997	0.00101	CcSEcCtD
Doxylamine—Anxiety—Doxorubicin—ovarian cancer	0.000992	0.001	CcSEcCtD
Doxylamine—Discomfort—Doxorubicin—ovarian cancer	0.000984	0.000995	CcSEcCtD
Doxylamine—Anorexia—Epirubicin—ovarian cancer	0.000983	0.000995	CcSEcCtD
Doxylamine—Dry mouth—Doxorubicin—ovarian cancer	0.000974	0.000985	CcSEcCtD
Doxylamine—Vomiting—Docetaxel—ovarian cancer	0.000972	0.000984	CcSEcCtD
Doxylamine—Rash—Docetaxel—ovarian cancer	0.000964	0.000975	CcSEcCtD
Doxylamine—Hypotension—Epirubicin—ovarian cancer	0.000964	0.000975	CcSEcCtD
Doxylamine—Dermatitis—Docetaxel—ovarian cancer	0.000963	0.000975	CcSEcCtD
Doxylamine—Confusional state—Doxorubicin—ovarian cancer	0.000962	0.000974	CcSEcCtD
Doxylamine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000954	0.000966	CcSEcCtD
Doxylamine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000936	0.000947	CcSEcCtD
Doxylamine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000934	0.000945	CcSEcCtD
Doxylamine—Insomnia—Epirubicin—ovarian cancer	0.000933	0.000944	CcSEcCtD
Doxylamine—Tachycardia—Doxorubicin—ovarian cancer	0.000931	0.000942	CcSEcCtD
Doxylamine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000923	0.000933	CcSEcCtD
Doxylamine—Dyspnoea—Epirubicin—ovarian cancer	0.00092	0.00093	CcSEcCtD
Doxylamine—Somnolence—Epirubicin—ovarian cancer	0.000917	0.000928	CcSEcCtD
Doxylamine—Anorexia—Doxorubicin—ovarian cancer	0.00091	0.00092	CcSEcCtD
Doxylamine—Nausea—Docetaxel—ovarian cancer	0.000908	0.000919	CcSEcCtD
Doxylamine—Decreased appetite—Epirubicin—ovarian cancer	0.000897	0.000907	CcSEcCtD
Doxylamine—Hypotension—Doxorubicin—ovarian cancer	0.000892	0.000902	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000891	0.000901	CcSEcCtD
Doxylamine—Fatigue—Epirubicin—ovarian cancer	0.000889	0.0009	CcSEcCtD
Doxylamine—Constipation—Epirubicin—ovarian cancer	0.000882	0.000892	CcSEcCtD
Doxylamine—Insomnia—Doxorubicin—ovarian cancer	0.000863	0.000873	CcSEcCtD
Doxylamine—Dyspnoea—Doxorubicin—ovarian cancer	0.000851	0.000861	CcSEcCtD
Doxylamine—Feeling abnormal—Epirubicin—ovarian cancer	0.00085	0.00086	CcSEcCtD
Doxylamine—Somnolence—Doxorubicin—ovarian cancer	0.000848	0.000858	CcSEcCtD
Doxylamine—Decreased appetite—Doxorubicin—ovarian cancer	0.00083	0.000839	CcSEcCtD
Doxylamine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000824	0.000834	CcSEcCtD
Doxylamine—Fatigue—Doxorubicin—ovarian cancer	0.000823	0.000832	CcSEcCtD
Doxylamine—Urticaria—Epirubicin—ovarian cancer	0.000819	0.000829	CcSEcCtD
Doxylamine—Constipation—Doxorubicin—ovarian cancer	0.000816	0.000826	CcSEcCtD
Doxylamine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000786	0.000796	CcSEcCtD
Doxylamine—Hypersensitivity—Epirubicin—ovarian cancer	0.00076	0.000769	CcSEcCtD
Doxylamine—Urticaria—Doxorubicin—ovarian cancer	0.000758	0.000767	CcSEcCtD
Doxylamine—Asthenia—Epirubicin—ovarian cancer	0.00074	0.000749	CcSEcCtD
Doxylamine—Pruritus—Epirubicin—ovarian cancer	0.00073	0.000738	CcSEcCtD
Doxylamine—Diarrhoea—Epirubicin—ovarian cancer	0.000706	0.000714	CcSEcCtD
Doxylamine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000703	0.000711	CcSEcCtD
Doxylamine—Asthenia—Doxorubicin—ovarian cancer	0.000685	0.000693	CcSEcCtD
Doxylamine—Dizziness—Epirubicin—ovarian cancer	0.000682	0.00069	CcSEcCtD
Doxylamine—Pruritus—Doxorubicin—ovarian cancer	0.000675	0.000683	CcSEcCtD
Doxylamine—Vomiting—Epirubicin—ovarian cancer	0.000656	0.000663	CcSEcCtD
Doxylamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000653	0.000661	CcSEcCtD
Doxylamine—Rash—Epirubicin—ovarian cancer	0.00065	0.000658	CcSEcCtD
Doxylamine—Dermatitis—Epirubicin—ovarian cancer	0.00065	0.000657	CcSEcCtD
Doxylamine—Dizziness—Doxorubicin—ovarian cancer	0.000631	0.000638	CcSEcCtD
Doxylamine—Tamoxifen—ABCB1—ovarian cancer	0.000613	0.0533	CrCbGaD
Doxylamine—Nausea—Epirubicin—ovarian cancer	0.000613	0.00062	CcSEcCtD
Doxylamine—Doxepin—ABCB1—ovarian cancer	0.000611	0.0531	CrCbGaD
Doxylamine—Methadone—ABCB1—ovarian cancer	0.000608	0.0528	CrCbGaD
Doxylamine—Vomiting—Doxorubicin—ovarian cancer	0.000607	0.000614	CcSEcCtD
Doxylamine—Rash—Doxorubicin—ovarian cancer	0.000602	0.000609	CcSEcCtD
Doxylamine—Dermatitis—Doxorubicin—ovarian cancer	0.000601	0.000608	CcSEcCtD
Doxylamine—Nausea—Doxorubicin—ovarian cancer	0.000567	0.000574	CcSEcCtD
Doxylamine—Imipramine—ABCB1—ovarian cancer	0.000476	0.0413	CrCbGaD
Doxylamine—Amitriptyline—ABCB1—ovarian cancer	0.000473	0.0411	CrCbGaD
